← Back
$VRTX All transactions

VERTEX PHARMACEUTICALS INC / MA

A

$ Value

Shares

1,001

Price

Filed

May 5

Insider

Name

MCKENZIE DIANA

Title

CIK

0001754648

Roles

Director

Transaction Details

Transaction Date

2025-05-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,991

Footnotes

Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. | Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2024, Ms. McKenzie deferred the receipt of 1,001 shares of common stock and received instead 1,001 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,001 shares of common stock in exchange for an equal number of deferred stock units. | Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death.

Filing Info

Accession No.

0000875320-25-000182

Form Type

4

Issuer CIK

0000875320

MCKENZIE DIANA's History

Date Ticker Type Value
2026-04-01 MET A $51K
2026-01-02 MET A $51K
2025-12-09 MET A $13K
2025-10-01 MET A $44K
2025-09-09 MET A $13K
2025-06-17 MET A $44K
2025-06-10 MET A $12K
2025-05-28 AGL A $0
2025-05-01 VRTX A $0
2025-05-01 VRTX D

Other Insiders at VRTX (90d)

Insider Bought Sold Last
SACHS BRUCE I 2026-04-15
WAGNER CHARLES F JR
EVP, CO & FO
2026-01-22
LEIDEN JEFFREY M
Executive Chairman
2026-01-22
Garber Alan M 2026-04-15
Sachdev Amit
EVP Chief Patient & Ext Af Off
2026-01-22
Upadhyay Suketu 2026-04-15
ALTSHULER DAVID
EVP, Chief Scientific Officer
2026-01-22
Kewalramani Reshma
CEO & President
2026-01-22
Biller Jonathan
EVP and Chief Legal Officer
2026-01-22
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
2026-01-22
Bozic Carmen
EVP and CMO
$1.1M 2026-03-27
Liu Joy
EVP and Chief Legal Officer
$439K 2026-04-01
Ambrose Kristen
SVP & Chief Accounting Officer
2026-01-22
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
2026-01-22
McKechnie Duncan
EVP, Chief Commercial Officer
2026-01-22